Influence of immunomodulatory drugs on the gut microbiota

被引:19
|
作者
Cohen, Inessa [1 ]
Ruff, William E. [1 ]
Longbrake, Erin E. [1 ]
机构
[1] Yale Univ, Dept Neurol, POB 208018, New Haven, CT 06520 USA
关键词
REGULATORY T-CELLS; CHAIN FATTY-ACIDS; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTOR; GLATIRAMER ACETATE; GASTROINTESTINAL TOXICITY; MYCOPHENOLATE-MOFETIL; INTESTINAL MICROBIOTA; PREVOTELLA-HISTICOLA; RHEUMATOID-ARTHRITIS;
D O I
10.1016/j.trsl.2021.01.009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Immunomodulatory medications are a mainstay of treatment for autoimmune diseases and malignancies. In addition to their direct effects on immune cells, these medications also impact the gut microbiota. Drug-induced shifts in commensal microbes can lead to indirect but important changes in the immune response. We performed a comprehensive literature search focusing on immunotherapy/microbe interactions. Immunotherapies were categorized into 5 subtypes based on their mechanisms of action: cell trafficking inhibitors, immune checkpoint inhibitors, immunomodulators, antiproliferative drugs, and inflammatory cytokine inhibitors. Although no consistent relationships were observed between types of immunotherapy and microbiota, most immunotherapies were associated with shifts in specific colonizing bacterial taxa. The relationships between colonizing microbes and drug efficacy were not well-studied for autoimmune diseases. In contrast, the efficacy of immune checkpoint inhibitors for cancer was tied to the baseline composition of the gut microbiota. There was a paucity of high-quality data; existing data were generated using heterogeneous sampling and analytic techniques, and most studies involved small numbers of participants. Further work is needed to elucidate the extent and clinical significance of immunotherapy effects on the human microbiome (Translational Research 2021; 233:144-161) Abbreviations: CD = cluster of differentiation; Th = helper T cells; Treg = regulatory T-cell subsets; GALT = gut-associated lymphoid tissue; TLR2 = Toll-like receptor-2; MMF = Mycophenolate mofetil; MTX = Methotrexate; RA = Rheumatoid Arthritis; MS = Multiple Sclerosis; MLGs = microbial linkage groups; ALZ = Alemtuzumab; CTLA-4 = cytotoxic T-lymphocyte-associated protein 4; PD-1 = programmed cell death protein 1; PD-L1 = programmed cell death protein 1 ligand 1; PD-L2 = programmed cell death protein 1 ligand 2; ICIs = Immune checkpoint inhibitors; NTZ = Natalizumab; LPS = lipopolysaccharide; DMF = Dimethyl fumarate; GA = Glatiramer acetate; IFNb = Interferon beta; TNFi's = TNF inhibitors; TNFa = tumor necrosis factor alpha; IgA = immu
引用
收藏
页码:144 / 161
页数:18
相关论文
共 50 条
  • [31] Calorie restriction mimetic drugs could favorably influence gut microbiota leading to lifespan extension
    Shintani, Tomoya
    Shintani, Hideya
    Sato, Masashi
    Ashida, Hisashi
    GEROSCIENCE, 2023, 45 (06) : 3475 - 3490
  • [32] Calorie restriction mimetic drugs could favorably influence gut microbiota leading to lifespan extension
    Tomoya Shintani
    Hideya Shintani
    Masashi Sato
    Hisashi Ashida
    GeroScience, 2023, 45 : 3475 - 3490
  • [33] Differential effects of the gut microbiota on the pharmacokinetics of antipsychotic drugs
    Walsh, Jacinta
    Cussotto, Sofia
    Strain, Conall R.
    Fouhy, Fiona
    Stanton, Catherine
    Dinan, Timothy G.
    Hyland, Niall P.
    Clarke, Gerard
    Cryan, John F.
    Griffin, Brendan T.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32
  • [34] Impact drugs targeting cardiometabolic risk on the gut microbiota
    Balvers, Manon
    van den Born, Bert-Jan H.
    Levin, Evgeni
    Nieuwdorp, Max
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (01) : 38 - 54
  • [35] Gut microbiota as an "invisible organ" that modulates the function of drugs
    Li, Xiang
    Liu, Linlin
    Cao, Zhiwen
    Li, Wen
    Li, Hui
    Lu, Cheng
    Yang, Xueqin
    Liu, Yuanyan
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [36] Interactions Between the Gut Microbiota and Common Cardiovascular Drugs
    Battle, Anna
    Lane, Ashlan
    Parish, Bailey
    Rushing, Sean
    Johnson, Jessica L.
    Weldon, Abby J.
    US PHARMACIST, 2023, 48 (02) : 18 - 21
  • [37] Gut microbiota and metabolic changes induced by psychotropic drugs
    Dubath, C.
    Camporesi, S.
    Choi, Y.
    Piras, M.
    von Gunten, A.
    Conus, P.
    Sentissi, O.
    Solida, A.
    Greub, G.
    Bertelli, C.
    Eap, C. B.
    SWISS MEDICAL WEEKLY, 2024, 154 : 130S - 130S
  • [38] Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link?
    Kyoung, Jun
    Atluri, Rohit R.
    Yang, Tao
    HYPERTENSION, 2022, 79 (10) : 2138 - 2147
  • [39] Human gut microbiota plays a role in the metabolism of drugs
    Jourova, Lenka
    Anzenbacher, Pavel
    Anzenbacherova, Eva
    BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (03): : 317 - 326
  • [40] Gut check: Unveiling the influence of acute exercise on the gut microbiota
    Grosicki, Gregory J.
    Langan, Sean P.
    Bagley, James R.
    Galpin, Andrew J.
    Garner, Dan
    Hampton-Marcell, Jarrad T.
    Allen, Jacob M.
    Robinson, Austin T.
    EXPERIMENTAL PHYSIOLOGY, 2023, 108 (12) : 1466 - 1480